These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 8126064

  • 21. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD.
    Surgery; 2003 May 15; 133(5):568-79. PubMed ID: 12773985
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.
    Seghezzi G, Marelli R, Mandriota SJ, Nolli ML, Mazzieri R, Mignatti P.
    J Cell Physiol; 1996 Nov 15; 169(2):300-8. PubMed ID: 8908197
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cell-associated activation of latent transforming growth factor-beta by calpain.
    Abe M, Oda N, Sato Y.
    J Cell Physiol; 1998 Feb 15; 174(2):186-93. PubMed ID: 9428805
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.
    Lab Invest; 1998 Sep 15; 78(9):1109-19. PubMed ID: 9759655
    [Abstract] [Full Text] [Related]

  • 30. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
    Pedrozo HA, Schwartz Z, Mokeyev T, Ornoy A, Xin-Sheng W, Bonewald LF, Dean DD, Boyan BD.
    J Cell Biochem; 1999 Jan 01; 72(1):151-65. PubMed ID: 10025676
    [Abstract] [Full Text] [Related]

  • 31. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 32. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.
    Oncogene; 2002 Nov 07; 21(51):7824-30. PubMed ID: 12420219
    [Abstract] [Full Text] [Related]

  • 33. Lipopolysaccharide inhibits activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S, Vernooy R, Moscatelli D, Amanuma H, Rifkin DB.
    J Cell Physiol; 1995 Apr 07; 163(1):210-9. PubMed ID: 7896898
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
    Melnick M, Chen H, Buckley S, Warburton D, Jaskoll T.
    Dev Dyn; 1998 Jan 07; 211(1):11-25. PubMed ID: 9438420
    [Abstract] [Full Text] [Related]

  • 36. Cell density dependent effects of TGF-beta demonstrated by a plasminogen activator-based assay for TGF-beta.
    Flaumenhaft R, Rifkin DB.
    J Cell Physiol; 1992 Jul 07; 152(1):48-55. PubMed ID: 1618922
    [Abstract] [Full Text] [Related]

  • 37. Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells.
    He CJ, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD.
    J Cell Physiol; 1991 Jan 07; 146(1):131-40. PubMed ID: 1846634
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.
    Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB.
    J Cell Biol; 1990 Aug 07; 111(2):757-63. PubMed ID: 1696270
    [Abstract] [Full Text] [Related]

  • 39. A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2.
    Strissel KJ, Rinehart WB, Fini ME.
    Invest Ophthalmol Vis Sci; 1995 Jan 07; 36(1):151-62. PubMed ID: 7822142
    [Abstract] [Full Text] [Related]

  • 40. Secretion of a TGF-beta-like growth inhibitor by normal rat mammary epithelial cells in vitro.
    Ethier SP, Van de Velde RM.
    J Cell Physiol; 1990 Jan 07; 142(1):15-20. PubMed ID: 2298817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.